Yeasen Biotechnology is a leading biotechnology company specializing in protein engineering and directed evolution technology. Since its establishment in 2014, Yeasen has been dedicated to the advancement of molecular enzymes and proteins within the life science sector. Leveraging our proprietary materials, we have undertaken the development of enzyme and reagents across three key categories: molecules, proteins, and cellular biology. These products cater to the demands of the life science research, molecular diagnostics, and biopharmaceutical industries. Over more than 10 years, Yeasen has evolved into a distinguished international high-tech enterprise, boasting self-reliant research and development as well as manufacturing capabilities.
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. (Stock Code: 668765) is a molecular pharmaceutical company specializing in the development, manufacturing, and marketing of recombinant proteins. Using its proprietary OryzHiExp platform, Healthgen achieves high-yield expression of proteins and peptides in rice grains. Its flagship product, Recombinant Human Serum Albumin (OsrHSA), is a critical reagent used in cell culture, medical devices, biopharmaceutical excipients, and cosmetic additives.
Wasatch BioLabs
Wasatch BioLabs (WBL) is an independent biotechnology company with a disruptive approach to research and diagnostics. We are an R&D and Oxford Nanopore Technologies-certified laboratory that offers DNA and RNA sequencing services to researchers and clinical service providers. WBL’s solutions span both standard Oxford Nanopore Technologies sequencing services as well as proprietary methylation sequencing services built off of WBL’s NESSI-Seq platform, that expand the capabilities of the nanopore platform. | Wasatch BioLabs, a leading NGS sequencing service provider, harnesses advanced native-read sequencing and streamlined R&D workflows—translating breakthrough discovery into real-world outcomes.
VION Biosciences
VION Biosciences is a specialized life science platform company focused on manufacturing and supplying mission-critical reagents, specialty chemicals, and assay kits for research, diagnostics, and drug development. We provide integrated, high-quality materials—including lipid nanoparticles and custom formulations—from discovery to commercialization. VION Biosciences aims to accelerate scientific research and clinical testing through innovation and flexible manufacturing solutions.
Vector Laboratories,Inc
Vector Laboratories is a reagents manufacturer and services provider, partnering with scientists to address today’s toughest biomedical challenges. Our product portfolio ranges from protein and glycan detection and visualization reagents to bioconjugation linker and dye technologies, all of which enable basic scientific discovery. Through custom products and services, including recombinant antibody engineering services, we help fuel our customers’ development of next-generation therapeutics. Vector Laboratories is building on 45+ years of expertise and an unparalleled reputation for a culture of service, proven products, and incomparable technical partnership. To learn more, visit the Vector Laboratories website.
UCSD Moores Cancer Center
As an NCI-designated Comprehensive Cancer Center, Moores Cancer Center at UC San Diego Health is among the top 4% of approximately 1,500 cancer centers in the United States, and one of only 58 Comprehensive Cancer Centers in the nation. Approximately 43,000 patients with cancer are seen at UC San Diego Health annually. Patients have access to clinical trials with a dedicated team, as well as to physicians who provide personalized care and are setting treatment standards nationwide for more than 200 types of cancer. According to the 2025-2026 U.S. News & World Report “Best Hospitals” survey, the UC San Diego Health cancer program was ranked 42nd in the nation.
TubeWriter
TubeWriter labeling systems is a full-feature instrument for printing directly at high-speed on the sides and caps of plastic, glass, and curved surfaces, including tubes, vials, slides, plates and custom labware. It is designed to address automating laboratory printing for assays, protocols and experiments. TubeWriter labeling withstands the harshest of lab conditions; resistant to chemical solvents and surviving long-term storage at -80C and liquid nitrogen. | TubeWriter is an automated labeling systems that prints directly on the surface of any labware eliminating the need for sticky labels. For laboratories that perform medium to high-throughput applications struggling with manual labeling or paper labels, the TubeWriter prints directly on the sides and caps of tubes, vials, plates and unique labware. TubeWriter prints text, images, and barcodes using UV-curable ink that withstands extreme lab conditions, most harsh chemicals and long-term storage at -80C and liquid nitrogen.
TOYOBO USA
In the 1950s, TOYOBO began investigating microorganisms for treating waste water from one of our plants that processed pulp for rayon. Scientists in our laboratories discovered that a certain type of yeast was consuming sugar in the waste water, substantially reducing the biochemical oxygen demand (BOD) level. We then filtered out the yeast to market it for animal food. As the proportion of nucleic acids in the yeast was extremely high, we separated them out and did research for use in food seasonings. In the 1960s, based on a success in commercializing uricase from Candida sp., the first of its kind, we expanded our focus to include the field of clinical chemistry. Now TOYOBO excels in the market with more than 60 kinds of material enzymes for diagnostic reagents. We also provide many kinds of materials and kits for research use at the forefront of the field of molecular biology. TOYOBO Healthcare products are renowned both in Japan and around the world for the finest level of quality on the market.
Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 2,800 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees across Asia Pacific, Europe, North America, Latin America and Africa. We are devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives. | Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are committed to moving our customers through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 54 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibility for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives. | Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 3,200 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees across Asia Pacific, Europe, North America, Latin America and Africa. We are devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.